Michael Jarjour - CareMax Chief Officer
| CMAX Stock | USD 0.0001 0.00 0.000003% |
Executive
Michael Jarjour is Chief Officer of CareMax
| Phone | 786 360 4768 |
| Web | https://www.caremax.com |
CareMax Management Efficiency
The company has return on total asset (ROA) of (0.1059) % which means that it has lost $0.1059 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2842) %, meaning that it created substantial loss on money invested by shareholders. CareMax's management efficiency ratios could be used to measure how well CareMax manages its routine affairs as well as how well it operates its assets and liabilities.CareMax currently holds 491.93 M in liabilities with Debt to Equity (D/E) ratio of 0.37, which is about average as compared to similar companies. CareMax has a current ratio of 5.94, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about CareMax's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Arthur Newman | HealthStream | 76 | |
| Linda Stacy | National Research Corp | 54 | |
| Jonathan Weinberg | Evolent Health | 53 | |
| Rona Anhalt | Certara | 60 | |
| John III | Certara | 52 | |
| Sarath Degala | Privia Health Group | N/A | |
| Michael Fiore | HealthEquity | N/A | |
| Andrew Monnich | National Research Corp | 49 | |
| Cheryl King | HealthEquity | N/A | |
| Kristen Berry | Health Catalyst | N/A | |
| Robert Borchert | Privia Health Group | N/A | |
| Jennifer Baron | National Research Corp | N/A | |
| Amanda Flanders | Health Catalyst | N/A | |
| Kevin JD | HealthStream | 55 | |
| Dana CPA | Privia Health Group | N/A | |
| Benjamin Landry | Health Catalyst | 43 | |
| Tarah Bryan | Health Catalyst | N/A | |
| Ryan Barry | Health Catalyst | N/A | |
| Brad Bennion | HealthEquity | N/A | |
| Daniel LeSueur | Health Catalyst | 47 | |
| Kevin Scharnhorst | Health Catalyst | N/A | |
Management Performance
| Return On Equity | -3.28 | |||
| Return On Asset | -0.11 |
CareMax Leadership Team
Elected by the shareholders, the CareMax's board of directors comprises two types of representatives: CareMax inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CareMax. The board's role is to monitor CareMax's management team and ensure that shareholders' interests are well served. CareMax's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CareMax's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alberto Solo, Executive COO | ||
| Carlos Solo, President, CoFounder | ||
| Samantha Swerdlin, Vice Relations | ||
| Niberto MD, Chief Officer | ||
| Nicole Cable, Chief Officer | ||
| Teresa McMeans, Chief Officer | ||
| Erick CPA, Chief Officer | ||
| Meredith Longsworth, General VP | ||
| Roger Ou, SVP Relations | ||
| Paul Rundell, Chief Officer | ||
| Meredith JD, General VP | ||
| Kevin Wirges, CFO VP | ||
| Erick Fernandez, Chief Officer | ||
| Mark Llorente, Chief Operations | ||
| Michael Jarjour, Chief Officer | ||
| Regla Wuilchrist, Chief Officer |
CareMax Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CareMax a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.28 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (1.00) % | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 496.78 M | |||
| Shares Outstanding | 3.81 M | |||
| Shares Owned By Insiders | 24.17 % | |||
| Shares Owned By Institutions | 39.77 % | |||
| Number Of Shares Shorted | 209.53 K | |||
| Price To Book | 0.55 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CareMax Stock Analysis
When running CareMax's price analysis, check to measure CareMax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CareMax is operating at the current time. Most of CareMax's value examination focuses on studying past and present price action to predict the probability of CareMax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CareMax's price. Additionally, you may evaluate how the addition of CareMax to your portfolios can decrease your overall portfolio volatility.